Prevalence and influencing factors of allergic rhinitis in Xi'an: A 2022 survey.

IF 2.8 Q3 ALLERGY

Asia Pacific Allergy Pub Date : 2026-05-01 Epub Date: 2026-01-13 DOI:10.5415/apallergy.0000000000000246

Xu Zhang, YunBo Gao, Jingyun Li, Lin Xi, Luo Zhang, Yuan Zhang

{"title":"Prevalence and influencing factors of allergic rhinitis in Xi'an: A 2022 survey.","authors":"Xu Zhang, YunBo Gao, Jingyun Li, Lin Xi, Luo Zhang, Yuan Zhang","doi":"10.5415/apallergy.0000000000000246","DOIUrl":null,"url":null,"abstract":"Background: The incidence of allergic rhinitis (AR) has been rising annually in China, correlating with the ongoing intensification of global climate change and industrialization.Objectives: This study aimed to investigate the self-reported prevalence of AR among adults in Xi'an, as well as the relevant influencing factors.Methods: The prevalence of AR was assessed among adult residents across 11 districts of Xi'an from June to October 2022. Additionally, an analysis was conducted to determine the relevant influencing factors associated with AR in these patients.Results: In total, 3,350 individuals from 11 districts in Xi'an participated in this survey, with a self-reported prevalence of 10.0%. Among AR patients, 20.1% had a family history of allergies, compared with 5.1% in those without AR. The prevalence of AR was 30.3% in patients with a family history of allergies and 8.5% in those without. Urban residents had a higher prevalence of AR (11.0%) than suburban residents (8.3%) (P = 0.002). Among the patients, 22.8% had perennial AR and 77.2% had seasonal AR, mainly due to pollen. In terms of diagnosis and treatment, 38.0% of the patients underwent allergen testing, 55.4% received medication, and 66.4% achieved symptom control.Conclusion: The incidence of AR in Xi'an remained high. This study will enhance the understanding of AR patterns in Xi'an and inform public health policies, prevention strategies, and AR control systems.","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"16 3","pages":"167-173"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13193259/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5415/apallergy.0000000000000246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The incidence of allergic rhinitis (AR) has been rising annually in China, correlating with the ongoing intensification of global climate change and industrialization.

Objectives: This study aimed to investigate the self-reported prevalence of AR among adults in Xi'an, as well as the relevant influencing factors.

Methods: The prevalence of AR was assessed among adult residents across 11 districts of Xi'an from June to October 2022. Additionally, an analysis was conducted to determine the relevant influencing factors associated with AR in these patients.

Results: In total, 3,350 individuals from 11 districts in Xi'an participated in this survey, with a self-reported prevalence of 10.0%. Among AR patients, 20.1% had a family history of allergies, compared with 5.1% in those without AR. The prevalence of AR was 30.3% in patients with a family history of allergies and 8.5% in those without. Urban residents had a higher prevalence of AR (11.0%) than suburban residents (8.3%) (P = 0.002). Among the patients, 22.8% had perennial AR and 77.2% had seasonal AR, mainly due to pollen. In terms of diagnosis and treatment, 38.0% of the patients underwent allergen testing, 55.4% received medication, and 66.4% achieved symptom control.

Conclusion: The incidence of AR in Xi'an remained high. This study will enhance the understanding of AR patterns in Xi'an and inform public health policies, prevention strategies, and AR control systems.

查看原文本刊更多论文

西安市2022年变应性鼻炎患病率及影响因素调查

背景：在中国，变应性鼻炎（AR）的发病率逐年上升，这与全球气候变化和工业化的持续加剧有关。目的：本研究旨在了解西安市成人AR自述患病率及其影响因素。方法：于2022年6月至10月对西安市11个区成年居民进行AR患病率评估。此外，我们还进行了分析，以确定这些患者发生AR的相关影响因素。结果：西安市11个区共3350人参与调查，自述患病率为10.0%。在AR患者中，有过敏家族史的比例为20.1%，无过敏家族史的比例为5.1%。有过敏家族史的患者中AR患病率为30.3%，无过敏家族史的患者中AR患病率为8.5%。城镇居民AR患病率（11.0%）高于郊区居民（8.3%）（P = 0.002）。多年生AR占22.8%，季节性AR占77.2%，主要由花粉引起。在诊断和治疗方面，38.0%的患者接受了过敏原检测，55.4%的患者接受了药物治疗，66.4%的患者获得了症状控制。结论：西安市急性呼吸道感染发生率居高不下。本研究将加强对西安市AR模式的了解，为公共卫生政策、预防策略和AR控制系统提供信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asia Pacific Allergy ALLERGY-

CiteScore

2.50

自引率

5.90%

发文量

期刊介绍： Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.